CS
KYTH

Credit Suisse’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Credit Suisse’s Portfolio KYTH Stock Details KYTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-147,892
Closed -$11.1M – 4544
2015
Q3 		$11.1M Buy
147,892
+36,565
+33% +$2.73M 0.01% 1057
2015
Q2 		$8.38M Buy
111,327
+81,045
+268% +$4.34M 0.01% 1370
2015
Q1 		$1.52M Buy
30,282
+2,780
+10% +$117K ﹤0.01% 2632
2014
Q4 		$954K Buy
27,502
+14,673
+114% +$512K ﹤0.01% 3170
2014
Q3 		$420K Sell
12,829
-588
-4% -$20.7K ﹤0.01% 3754
2014
Q2 		$514K Sell
13,417
-2,151
-14% -$75.1K ﹤0.01% 3807
2014
Q1 		$619K Sell
15,568
-2,602
-14% -$116K ﹤0.01% 3546
2013
Q4 		$678K Buy
+18,170
New +$754K ﹤0.01% 3568

Credit Suisse's KYTH Position: Q4 2015 in Review

Credit Suisse sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 147,892 shares — an estimated $11.1M sold.

Credit Suisse first reported a position in KYTH in Q4 2013 and held it in 8 quarters. The position peaked at $11.1M in Q3 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

  • Credit Suisse reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
  • Credit Suisse sold 147,892 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $11.1M.
  • Credit Suisse first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q4 2013 and held it in 8 quarters.
  • Credit Suisse's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $11.1M in Q3 2015.
  • 0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on Credit Suisse's 13F filing for Q4 2015, filed 16 Feb 2016.